"Factors influencing receipt and time to treatment of immunotherapy relative to chemotherapy in stage III and stage IV melanoma"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Immunotherapies have changed the landscape of late‐stage melanoma; however, data evaluating timely access to immunotherapy are lacking. Click to show full abstract

Immunotherapies have changed the landscape of late‐stage melanoma; however, data evaluating timely access to immunotherapy are lacking.

Keywords: stage melanoma; influencing receipt; immunotherapy; stage; factors influencing

Journal Title: Cancer Medicine
Year Published: 2024

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
0

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended